Table 1. Correlation between clinical characteristic parameters and ADARB1 expression in LUAD.
| Variables | Number | Mean ± SD | P |
|---|---|---|---|
| Gender | 0.001 | ||
| Male | 208 | 8.426 ± 0.901 | |
| Female | 249 | 8.693 ± 0.781 | |
| Pathologic T | 0.123 | ||
| T1/T1a/T1b | 140 | 8.724 ± 0.795 | |
| T2/T2a/T2b | 256 | 8.504 ± 0.872 | |
| T3 | 41 | 8.514 ± 0.902 | |
| T4 | 18 | 8.539 ± 0.672 | |
| TX | 2 | 8.025 ± 0.474 | |
| Pathologic N | 0.37 | ||
| N0 | 290 | 8.617 ± 0.820 | |
| N1 | 85 | 8.442 ± 0.806 | |
| N2 | 70 | 8.501 ± 1.005 | |
| N3 | 2 | 8.784 ± 0.276 | |
| NX | 9 | 8.831 ± 0.822 | |
| Pathologic M | 0 | ||
| M0 | 313 | 8.489 ± 0.858 | |
| M1/M1a/M1b | 22 | 8.201 ± 0.872 | |
| MX | 118 | 8.860 ± 0.745 | |
| Pathologic tumor stage | 0.229 | ||
| Stage I/IA/IB | 246 | 8.606 ± 0.812 | |
| Stage IIA/IIB | 108 | 8.609 ± 0.851 | |
| Stage IIIA/IIIB | 79 | 8.509 ± 0.935 | |
| Stage IV | 23 | 8.251 ± 0.885 | |
| Race | 0.563 | ||
| WHITE | 356 | 8.612 ± 0.846 | |
| BLACK OR AFRICAN AMERICAN | 26 | 8.428 ± 0.887 | |
| ASIAN | 7 | 8.633 ± 0.791 | |
| Age | 0.171 | ||
| ≤60 | 137 | 8.491 ± 0.897 | |
| >60 | 301 | 8.611 ± 0.830 | |
| Residual tumor | 0.209 | ||
| RX | 17 | 8.609 ± 0.681 | |
| R0 | 315 | 8.489 ± 0.836 | |
| R1 | 11 | 8.985 ± 0.698 | |
| R2 | 4 | 8.233 ± 0.484 | |
| Tobacco smoking history indicator | 0.297 | ||
| Current reformed smoker for > 15 years | 115 | 8.590 ± 0.764 | |
| Current reformed smoker for < or = 15 years | 153 | 8.574 ± 0.845 | |
| Current Reformed Smoker, Duration Not Specified | 2 | 8.185 ± 1.722 | |
| Lifelong Non-smoker | 69 | 8.738 ± 0.806 | |
| Current smoker | 106 | 8.464 ± 0.916 |